Related Experiment Video
Updated: Jun 16, 2026
09:08
Precision Cut Lung Slices as an Efficient Tool for Ex vivo Pulmonary Vessel Structure and Contractility Studies
Published on: May 24, 2021
Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease
S Pabst1, B Theis, A Gillissen
1Medizinische Klinik und Poliklinik II, Pulmonary Division, Department of Medicine, Universitätsklinikum Bonn, Bonn, Germany. Stefan.pabst@ukb.uni-bonn.de
European Journal of Medical Research
|February 17, 2010
Summary
The angiotensin-converting enzyme (ACE) I-allele is linked to a higher risk and a more stable course of chronic obstructive lung disease (COPD). This genetic factor may influence disease progression in COPD patients.
Area of Science:
- Genetics
- Pulmonology
- Molecular Biology
Background:
- The exact causes of chronic obstructive lung disease (COPD) remain unclear, with theories pointing to environmental factors like tobacco smoke and genetic predispositions.
- The angiotensin-converting enzyme (ACE) gene exhibits a common polymorphism (I/D) influencing its activity and potentially disease susceptibility or course.
Purpose of the Study:
- To investigate the association between the angiotensin-converting enzyme (ACE) gene polymorphism and the clinical course of chronic obstructive lung disease (COPD).
- To determine if specific ACE genotypes correlate with disease stability or instability in COPD patients.
Main Methods:
- Genotyping of the ACE (I/D) polymorphism in 152 Caucasian COPD patients and 158 healthy controls.
- Categorization of COPD patients into stable (≤3 hospitalizations in 3 years) and unstable (>3 hospitalizations in 3 years) groups based on hospitalization history.
Main Results:
- The I-allele of the ACE gene was significantly associated with an increased risk of developing COPD (dominant model, OR 1.67).
- A significant increase in the ACE I-allele was observed in COPD patients with a stable disease course compared to controls (p=0.012).
- The association between the ACE I-allele and a stable COPD course was stronger in a dominant model (II/ID vs DD, OR 3.24, p=0.003).
Conclusions:
- The presence of the ACE I-allele appears to be a determinant factor for a stable course of chronic obstructive lung disease (COPD).
- These findings suggest a potential role for ACE gene variants in modulating COPD progression and clinical outcomes.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.